LG
GILD icon

LaFleur & Godfrey’s Gilead Sciences GILD Stock Holding History

LaFleur & Godfrey’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-77,704
Closed -$5.25M – 72
2019
Q2 		$5.25M Sell
77,704
-1,423
-2% -$93.6K 1.31% 29
2019
Q1 		$5.14M Sell
79,127
-32,344
-29% -$2.15M 1.33% 29
2018
Q4 		$6.97M Sell
111,471
-21,023
-16% -$1.47M 1.97% 21
2018
Q3 		$10.2M Buy
132,494
+26,626
+25% +$2.01M 2.46% 16
2018
Q2 		$7.5M Buy
105,868
+6,006
+6% +$424K 1.87% 24
2018
Q1 		$7.53M Buy
99,862
+36,230
+57% +$2.88M 1.89% 23
2017
Q4 		$4.56M Buy
+63,632
New +$4.83M 1.12% 33

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LaFleur & Godfrey's GILD Position: Q3 2019 in Review

LaFleur & Godfrey sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 77,704 shares — an estimated $5.25M sold.

LaFleur & Godfrey first reported a position in GILD in Q4 2017 and held it in 7 quarters. The position peaked at $10.2M in Q3 2018. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • LaFleur & Godfrey reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • LaFleur & Godfrey sold 77,704 Gilead Sciences shares in Q3 2019, an estimated $5.25M.
  • LaFleur & Godfrey first reported a position in Gilead Sciences in Q4 2017 and held it in 7 quarters.
  • LaFleur & Godfrey's Gilead Sciences position peaked at $10.2M in Q3 2018.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on LaFleur & Godfrey's 13F filing for Q3 2019, filed 29 Oct 2019.